Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2024-04-08
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Caffeinated Chewing Gum on 400-meter Performance
NCT06430996
Carbohydrate Rinsing and Caffeine Gum on Performance of Romanian Deadlifts Performance
NCT05900349
Caffeinated Chewing Gum & Wrestling Performance
NCT06758336
Caffeinate Chewing Gum on Ice Hockey Performance
NCT06557655
Effects of Caffeine and Nicotine Gum on Balance Performance in Athletes
NCT07254832
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
caffeine gum
Chewing caffeine Gum (CAF trial, containing 5 mg/kg of caffeine) for 10 minutes before test.
caffeine
The participants chewed either caffeine gum (5 mg/kg for 10 minutes per chew) or a placebo (10 minutes per chew, using regular gum).
placebo
Chewing placebo gum (without caffeine) for 10 minutes before test.
caffeine
The participants chewed either caffeine gum (5 mg/kg for 10 minutes per chew) or a placebo (10 minutes per chew, using regular gum).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
caffeine
The participants chewed either caffeine gum (5 mg/kg for 10 minutes per chew) or a placebo (10 minutes per chew, using regular gum).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having no cardiovascular or joint diseases
* being an adult male
Exclusion Criteria
* cardiovascular or joint disease, or any other condition that could be impaired by exercise
* female and underage participants
* previous caffeine allergy
20 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chih-Hui Chiu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chih-Hui Chiu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ChihHui Chiu, PhD
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University of Sport
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University of Sport
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Liu HS, Okada T, Mitsuya H, Hsieh MH, Hou CW, Chang CC, Chiu CH. Effects of caffeinated chewing gum-induced sympathetic activation and diuretic effect on the rapid rate of weight loss in bodybuilders: a double-blind crossover study. BMC Sports Sci Med Rehabil. 2025 Apr 26;17(1):98. doi: 10.1186/s13102-025-01144-z.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
113-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.